Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
Nature Medicine2007Vol. 13(4), pp. 492–497
Citations Over TimeTop 1% of 2007 papers
Katarzyna Z. Maresz, Gareth Pryce, Eugene D. Ponomarev, Giovanni Marsicano, J. Ludovic Croxford, Leah P. Shriver, Catherine Ledent, Xiaodong Cheng, Erica J. Carrier, Monica Mann, Gavin Giovannoni, Roger G. Pertwee, Takashi Yamamura, Nancy E. Buckley, Cecilia J. Hillard, Beat Lutz, David Baker, Bonnie N. Dittel
Related Papers
- → Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor(2000)541 cited
- → Targeting cannabinoid agonists for inflammatory and neuropathic pain(2007)101 cited
- → Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors(2004)99 cited
- → Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists(2008)88 cited
- → Identification and biochemical analyses of selective CB2 agonists(2019)10 cited